Recombinant Human CD22β/Siglec-2
- -
- -
BackgroundCD22β, also known as Siglec-2, is a type 1 integral membrane glycoprotein belonging to the Ig family. It is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases. CD22β specifically recognizes sialic acid-containing glycans and is expressed on B cells (1). Both biochemical analysis on various B cells and studies using CD22β-deficient mice have demonstrated that CD22β negatively regulates signaling through the B cell antigen receptor (BCR), which plays a crucial role in response of B cells to antigen stimulation (2). CD22β does this by recruitment and activation of SH2-containing phosphatase 1 (SHP-1), which counteracts the phospharylation-mediated activation of signaling molecules by dephosphorylation, and reduces Ca2+ signaling by regulating the activity of the Ca2+ pump PMCA (3). Unlike other B cell markers, CD22β membrane expression is limited to the late differentiation stages comprised between mature B cells (CD22+) and plasma cells (CD22-), and may thus prove useful in phenotyping mature leukemias (4). CD22β is also strongly expressed in hairy cell leukemia. Protein DetailsPurity >95% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <1.0 EU/µg as determined by the LAL method Fusion Protein Tag Fc Fusion Protein Protein Accession No. Amino Acid Sequence dsskwvfehp etlyawegac vwipctyral dgdlesfilf hnpeynknts kfdgtrlyes tkdgkvpseq krvqflgdkn knctlsihpv hlndsgqlgl rmesktekwm erihlnvser pfpphiqlpp eiqesqevtl tcllnfscyg ypiqlqwlle gvpmrqaavt stsltiksvf trselkfspq wshhgkivtc qlqdadgkfl sndtvqlnvk htpkleikvt psdaivregd svtmtcevss snpeyttvsw lkdgtslkkq ntftlnlrev tkdqsgkycc qvsndvgpgr seevflqvqy apepstvqil hspavegsqv eflcmslanp lptnytwyhn gkemqgrtee kvhipkilpw hagtyscvae nilgtgqrgp gaeldvqypp kkvttviqnp mpiregdtvt lscnynssnp svtryewkph gaweepslgv lkiqnvgwdn ttiacarcns wcswaspval nvqyaprdvr vrkikplsei hsgnsvslqc dfssshpkev qffwekngrl lgkesqlnfd sispedagsy scwvnnsigq taskawtlev lyaprrlrvs mspgdqvmeg ksatltcesd anppvshytw fdwnnqslph hsqklrlepv kvqhsgaywc qgtnsvgkgr splstltvyy spetigrrdi egrmdpkscd kthtcppcpa pellggpsvf lfppkpkdtl misrtpevtc vvvdvshedp evkfnwyvdg vevhnaktkp reeqynstyr vvsvltvlhq dwlngkeykc kvsnkalpap iektiskakg qprepqvytl ppsrdeltkn qvsltclvkg fypsdiavew esngqpenny kttppvldsd gsfflysklt vdksrwqqgn vfscsvmhea lhnhytqksl slspgk N-terminal Sequence Analysis Asp20 State of Matter Lyophilized Predicted Molecular Mass The predicted molecular weight of Recombinant Human is Mr 101.9 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 122-127 kDa. Predicted Molecular Mass 101.9 Formulation This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives. Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Next Day Ambient NCBI Gene Bank References & Citations1. Sgroi, D. et al. (1993) J. Biol. Chem. 268:7011 2. Poe, JC. et al. (2004) Nature Immunol. 5:1078 3. Tsubata, T. et al. (2001) J. Biol. Chem. 276:26648 4. Van Rossenberg, S. et al. (2001) J. Biol. Chem. 276:12967 Technical ProtocolsCertificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
